Riluzole (Rilutek) is a drug used to treat amyotrophic lateral sclerosis marketed by Sanofi-Aventis. It delays the onset of ventilator-dependence or tracheostomy in selected patients and may increase survival by approximately two-to-three months.
This page contains content from the copyrighted Wikipedia article "Riluzole"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.